NICE recommends thalidomide ahead of Velcade
July 27, 2011Sales and Marketing NICE, Thalidomide, Velcade
NICE has recommended Celgene’s thalidomide ahead of J&J’s Velcade for multiple myeloma. Celgene’s drug is recommended in combination with an …
Contract research news in brief
July 27, 2011Research and Development research and development news
PPD plays down sell-off rumours, Icon sees a steep profit decline, plus updates from Beaufort, PharmaNet, ClinStar and Biofocus/IMD. PPD …
Open Health appoints three new partners
July 26, 2011Medical Communications apppointment, medical communications
New UK comms agency Open Health has strengthened its management team, appointing three new partners. Andy Bell, Cory Inglis and …
Augmentin recall expanded on contamination fears
July 26, 2011Manufacturing and Production, Sales and Marketing Augmentin, GSK, recalls
GlaxoSmithKline has been drawn further into concerns about contamination of pharmaceuticals, foods and beverages with plasticiser compounds, after authorities in …
NICE consults on asthma drug reducing procedure
July 26, 2011Sales and Marketing NICE, asthma
NICE has launched a consultation in the UK on a new medical procedure which, if it proves safe and effective, …
Janssen’s prostate cancer drug gains European backing
July 26, 2011Sales and Marketing Zytiga, prostate cancer
Janssen’s prostate cancer treatment Zytiga has been recommended by Europe’s CHMP, paving the way for possible third quarter launch. The …
Boost for Ireland’s pharma sector as new facility announced
July 26, 2011Manufacturing and Production Sangart, pharma manfacturing news, pharma manufacturing news
Around 120 jobs will be created in Cork, Ireland, thanks to a decision by pharmaceutical company Sangart to build a …
Baxter fined for workplace safety violations
July 26, 2011Manufacturing and Production Baxter International, pharma manufacturing news
Baxter Healthcare has been fined $371,000 by the California state authorities for “deliberate and wilful” workplace safety violations at a …
The format for the submission of information on medicines is published
July 25, 2011The European Medicines Agency has recently published the format in which pharmaceutical companies will need to submit information regarding authorised …
FDA sets aside $700,000 for manufacturing research
July 25, 2011Manufacturing and Production FDA, pharma manufacturing news
The FDA has set aside $700,000 to help fund research that “improves reliability of pharmaceutical product manufacturing and quality across …
Pharma manufacturing news in brief
July 25, 2011Manufacturing and Production pharma manufacturing news
Another recall for generics manufacturer American Regent, facility updates from Sanofi, Beximco, Lanxess and Anomatic, plus a new general manager …
BMS makes $325m biotech acquisition
July 25, 2011Research and Development, Sales and Marketing BMS, biotech, research and development news
Bristol-Myers Squibb is to plug gaps in its pipeline by buying private biotech company Amira Pharmaceuticals for $325 million in …
Roche cancer drug Tarceva set for first-line licence
July 25, 2011Sales and Marketing Cancer, Roche, Tarceva
Roche’s cancer drug Tarceva is on course to win a first-line indication in Europe for the first time after regulatory …
Afinitor poised to realise blockbuster ambitions?
July 25, 2011Sales and Marketing Afinitor, Cancer, Novartis
Novartis’ Afinitor may be set to make good on its blockbuster promise after receiving European backing for its second licence …
Sanofi bags GSK’s Anne Whitaker for US role
July 25, 2011Research and Development, Sales and Marketing appointment, research and development, sales and marketing
Sanofi has appointed Anne Whitaker president of its US pharmaceutical operations. She joins the company from GlaxoSmithKline, where she served …
Digital Pharma: Pfizer’s Facebook page hacked
July 22, 2011Medical Communications Digital Pharma blog, Facebook, Pfizer
Pfizer has regained control of its corporate Facebook page after hackers temporarily defaced it earlier this week. A UK group …
Lilly posts strong quarterly results, faces challenges ahead
July 22, 2011Sales and Marketing lilly, patent expiry
Lilly edged toward double-digit growth in the second quarter, but looming patent expires threaten this trend. Second quarter revenue grew …
Teva closes one Canadian plant, expands two more
July 22, 2011Manufacturing and Production Canada, Teva
Teva Pharmaceutical has decided to shut down its recently-acquired manufacturing Canadian facility in Montreal, Quebec, having failed to find a …
Merck and Roche extend Victrelis co-promotion deal to Europe
July 22, 2011Sales and Marketing Merck & Co, Roche, Victrelis, hepatitis C
Merck & Co is ramping up efforts to push its new hepatitis C treatment Victrelis to the fore, signing a …
European reprieve for Takeda’s Actos
July 22, 2011Sales and Marketing Actos, diabetes
Takeda’s Actos is likely to remain on the market in Europe but regulators want the diabetes drug to carry stronger …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
